GoodRx Holdings (GDRX) Cash from Operations (2019 - 2025)
GoodRx Holdings (GDRX) has disclosed Cash from Operations for 7 consecutive years, with 32888000.0 as the latest value for Q4 2025.
- Quarterly Cash from Operations fell 26.5% to 32888000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 167904000.0 through Dec 2025, down 8.69% year-over-year, with the annual reading at 167904000.0 for FY2025, 8.69% down from the prior year.
- Cash from Operations hit 32888000.0 in Q4 2025 for GoodRx Holdings, down from 76023000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 86862000.0 in Q3 2024 to a low of 9413000.0 in Q1 2025.
- Historically, Cash from Operations has averaged 40782350.0 across 5 years, with a median of 38756000.0 in 2021.
- Biggest YoY gain for Cash from Operations was 411.08% in 2025; the steepest drop was 77.9% in 2025.
- Year by year, Cash from Operations stood at 49810000.0 in 2021, then crashed by 36.0% to 31879000.0 in 2022, then crashed by 50.22% to 15868000.0 in 2023, then soared by 181.97% to 44743000.0 in 2024, then decreased by 26.5% to 32888000.0 in 2025.
- Business Quant data shows Cash from Operations for GDRX at 32888000.0 in Q4 2025, 76023000.0 in Q3 2025, and 49580000.0 in Q2 2025.